OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aryl Hydrocarbon Receptor Connects Inflammation to Breast Cancer
Tiziana Guarnieri
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5264-5264
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Targeted Therapy and Mechanisms of Drug Resistance in Breast Cancer
Briana Kinnel, Santosh Kumar Singh, Gabriela Oprea‐Ilies, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1320-1320
Open Access | Times Cited: 79

Aryl Hydrocarbon Receptor and Its Diverse Ligands and Functions: An Exposome Receptor
Lucie Larigot, Louise Benoit, Meriem Koual, et al.
The Annual Review of Pharmacology and Toxicology (2021) Vol. 62, Iss. 1, pp. 383-404
Open Access | Times Cited: 63

Host/microbiota interactions-derived tryptophan metabolites modulate oxidative stress and inflammation via aryl hydrocarbon receptor signaling
Yue-Qi Tan, Yanni Wang, Hao-Yu Feng, et al.
Free Radical Biology and Medicine (2022) Vol. 184, pp. 30-41
Closed Access | Times Cited: 46

Oxidative Stress in Breast Cancer: A Biochemical Map of Reactive Oxygen Species Production
Lyudmila V. Bel’skaya, Elena I. Dyachenko
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 4646-4687
Open Access | Times Cited: 13

Healthy lifestyles, systemic inflammation and breast cancer risk: a mediation analysis
Yanyu Zhang, Mengjie Song, Zixuan Yang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 10

Kynurenic Acid/AhR Signaling at the Junction of Inflammation and Cardiovascular Diseases
A. Yu. Grishanova, M. L. Perepechaeva
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6933-6933
Open Access | Times Cited: 10

The AHR–NRF2–JDP2 gene battery: Ligand–induced AHR transcriptional activation
Kenly Wuputra, Wen-Hung Hsu, Chia‐Chen Ku, et al.
Biochemical Pharmacology (2025) Vol. 233, pp. 116761-116761
Open Access | Times Cited: 1

The Role of the Aryl Hydrocarbon Receptor (AhR) and Its Ligands in Breast Cancer
Stephen Safe, Lei Zhang
Cancers (2022) Vol. 14, Iss. 22, pp. 5574-5574
Open Access | Times Cited: 38

Aryl Hydrocarbon Receptors: Evidence of Therapeutic Targets in Chronic Inflammatory Skin Diseases
Han-Bi Kim, Ji‐Young Um, Bo Young Chung, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1087-1087
Open Access | Times Cited: 21

Environmental exposure and the role of AhR in the tumor microenvironment of breast cancer
Colleen Sweeney, Gwendal Lazennec, Christoph F.A. Vogel
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19

Interplay between Estrogen, Kynurenine, and AHR Pathways: An immunosuppressive axis with therapeutic potential for breast cancer treatment
Jorge H. Limón-Pacheco, Guillermo Elizondo
Biochemical Pharmacology (2023) Vol. 217, pp. 115804-115804
Closed Access | Times Cited: 12

Tryptophan catabolism via the kynurenine pathway regulates infection and inflammation: from mechanisms to biomarkers and therapies
Jingpu Zhang, Yanlei Liu, Xiao Zhi, et al.
Inflammation Research (2024) Vol. 73, Iss. 6, pp. 979-996
Closed Access | Times Cited: 4

Multi-Drug Resistance and Breast Cancer Progression via Toll-Like Receptors (TLRs) Signaling
Harikumar Pallathadka, Abdulrahman Qais Khaleel, Ahmed Hussein Zwamel, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 4, pp. 3015-3030
Closed Access | Times Cited: 4

The AhR pathway regulation in phthalates-induced cancer promotion, progression and metastasis: a scoping review
Mostafa Akbariani, Mahmoud Omidi, Zohreh Shahabi, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access

Polycyclic aromatic hydrocarbon-aryl hydrocarbon receptor signaling regulates chronic inflammation in lung-gut axis
Tzu-Yu Cheng, Ching-Shan Luo, Po‐Hao Feng, et al.
Toxicology and Applied Pharmacology (2025), pp. 117359-117359
Closed Access

TDO2 and tryptophan metabolites promote kynurenine/AhR signals to facilitate glioma progression and immunosuppression.
Chuanhong Zhong, Lilei Peng, Bei Tao, et al.
PubMed (2022) Vol. 12, Iss. 6, pp. 2558-2575
Closed Access | Times Cited: 15

The Anticancer Effects of the Garlic Organosulfide Diallyl Trisulfide through the Attenuation of B[a]P-Induced Oxidative Stress, AhR Expression, and DNA Damage in Human Premalignant Breast Epithelial (MCF-10AT1) Cells
Dominique T. Ferguson, Equar Taka, Syreeta L. Tilghman, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 923-923
Open Access | Times Cited: 3

Constitutive TDO2 expression promotes liver cancer progression by an autocrine IL-6 signaling pathway
Zhengzhong Wu, Leye Yan, Junqing Lin, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 20

Postnatal administration of S-adenosylmethionine restores developmental AHR activation-induced deficits in CD8+ T-cell function during influenza A virus infection
Christina M. Post, Jason R. Myers, Bethany Winans, et al.
Toxicological Sciences (2023) Vol. 192, Iss. 2, pp. 233-246
Open Access | Times Cited: 8

Therapeutic effects of in vivo administration of an inhibitor of tryptophan 2,3-dioxygenase (680c91) for the treatment of fibroids: a preclinical study
Tsai‐Der Chuang, Nhu Ton, Shawn Rysling, et al.
Fertility and Sterility (2023) Vol. 121, Iss. 4, pp. 669-678
Open Access | Times Cited: 8

Breast cancer progression and kynurenine pathway enzymes are induced by hexachlorobenzene exposure in a Her2-positive model
Lorena V. Zárate, Noelia Miret, Alejandro J. Nicola Candia, et al.
Food and Chemical Toxicology (2023) Vol. 177, pp. 113822-113822
Closed Access | Times Cited: 7

Regulation of IDO2 by the Aryl Hydrocarbon Receptor (AhR) in Breast Cancer
Sarah Y. Kado, Keith J. Bein, Alejandro R. Castañeda, et al.
Cells (2023) Vol. 12, Iss. 10, pp. 1433-1433
Open Access | Times Cited: 7

AhR agonist tapinarof ameliorates lupus autoimmunity by suppressing Tfh cell differentiation via regulation of the JAK2‐STAT3 signaling pathway
Ying Zhang, Yanyan Pan, Peiyi Zhang, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 7

Page 1 - Next Page

Scroll to top